A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma
| Autor: | Liu, Xiaoqian, Zhang, Yuanfeng, Li, Kaimin, Liu, Yinghui, Xu, Junqing, Ma, Junjie, An, Licai, Wang, Hui, Chu, Xiaoxia |
|---|---|
| Zdroj: | In Translational Oncology July 2021 14(7) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|